PURA VIDA INVESTMENTS, LLC - Q3 2019 holdings

Add to watchlist

$585 Million is the total value of PURA VIDA INVESTMENTS, LLC's 90 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 100.0% .

All

			Value		Shares		↓ Weighting
SYNH	Exit	SYNEOS HEALTH INCcl a	$0	–	-5,000	-100.0%	-0.04%	–
VTGN	Exit	VISTAGEN THERAPEUTICS INC	$0	–	-425,000	-100.0%	-0.05%	–
ACST	Exit	ACASTI PHARMA INCcl a new	$0	–	-333,099	-100.0%	-0.06%	–
	Exit	APTOSE BIOSCIENCES INC	$0	–	-150,000	-100.0%	-0.06%	–
AMRS	Exit	AMYRIS INC	$0	–	-247,668	-100.0%	-0.13%	–
QTNT	Exit	QUOTIENT LTDcall	$0	–	-112,500	-100.0%	-0.16%	–
IART	Exit	INTEGRA LIFESCIENCES HLDGS C	$0	–	-25,000	-100.0%	-0.21%	–
ADPT	Exit	ADAPTIVE BIOTECHNOLOGIES COR	$0	–	-35,000	-100.0%	-0.26%	–
PSNL	Exit	PERSONALIS INC	$0	–	-65,000	-100.0%	-0.27%	–
CRY	Exit	CRYOLIFE INC	$0	–	-70,000	-100.0%	-0.32%	–
LIVN	Exit	LIVANOVA PLC	$0	–	-30,000	-100.0%	-0.33%	–
GKOS	Exit	GLAUKOS CORP	$0	–	-30,000	-100.0%	-0.34%	–
INCY	Exit	INCYTE CORP	$0	–	-28,318	-100.0%	-0.36%	–
BEAT	Exit	BIOTELEMETRY INCput	$0	–	-50,000	-100.0%	-0.37%	–
SILK	Exit	SILK RD MED INC	$0	–	-50,000	-100.0%	-0.37%	–
AXNX	Exit	AXONICS MODULATION TECHNOLOG	$0	–	-65,000	-100.0%	-0.40%	–
CNCE	Exit	CONCERT PHARMACEUTICALS INCcall	$0	–	-224,900	-100.0%	-0.41%	–
LIVN	Exit	LIVANOVA PLCput	$0	–	-40,000	-100.0%	-0.44%	–
ARAY	Exit	ACCURAY INCcall	$0	–	-800,000	-100.0%	-0.47%	–
VAPO	Exit	VAPOTHERM INC	$0	–	-140,000	-100.0%	-0.49%	–
INGN	Exit	INOGEN INCcall	$0	–	-50,000	-100.0%	-0.51%	–
WMGI	Exit	WRIGHT MED GROUP N V	$0	–	-122,500	-100.0%	-0.56%	–
BRKS	Exit	BROOKS AUTOMATION INC NEW	$0	–	-95,000	-100.0%	-0.56%	–
AVNS	Exit	AVANOS MED INC	$0	–	-85,000	-100.0%	-0.56%	–
ITCI	Exit	INTRA CELLULAR THERAPIES INCcall	$0	–	-300,000	-100.0%	-0.59%	–
AXGN	Exit	AXOGEN INCput	$0	–	-200,000	-100.0%	-0.60%	–
OMCL	Exit	OMNICELL COMput	$0	–	-50,000	-100.0%	-0.65%	–
CTLT	Exit	CATALENT INC	$0	–	-80,000	-100.0%	-0.66%	–
AMRN	Exit	AMARIN CORP PLCspons adr new	$0	–	-235,204	-100.0%	-0.69%	–
AVTR	Exit	AVANTOR INC	$0	–	-250,000	-100.0%	-0.72%	–
GKOS	Exit	GLAUKOS CORPcall	$0	–	-65,000	-100.0%	-0.74%	–
OFIX	Exit	ORTHOFIX MED INC	$0	–	-93,794	-100.0%	-0.75%	–
BRKR	Exit	BRUKER CORP	$0	–	-100,000	-100.0%	-0.76%	–
MYGN	Exit	MYRIAD GENETICS INCcall	$0	–	-200,000	-100.0%	-0.84%	–
ABBV	Exit	ABBVIE INC	$0	–	-79,980	-100.0%	-0.88%	–
PPH	Exit	VANECK VECTORS ETF TRput	$0	–	-100,000	-100.0%	-0.89%	–
MMSI	Exit	MERIT MED SYS INCput	$0	–	-100,000	-100.0%	-0.90%	–
GH	Exit	GUARDANT HEALTH INC	$0	–	-70,000	-100.0%	-0.92%	–
ARQL	Exit	ARQULE INC	$0	–	-633,789	-100.0%	-1.06%	–
DHR	Exit	DANAHER CORPORATION	$0	–	-50,000	-100.0%	-1.08%	–
ABMD	Exit	ABIOMED INCput	$0	–	-30,000	-100.0%	-1.19%	–
IRTC	Exit	IRHYTHM TECHNOLOGIES INCput	$0	–	-100,000	-100.0%	-1.20%	–
GMED	Exit	GLOBUS MED INCput	$0	–	-200,000	-100.0%	-1.28%	–
INCY	Exit	INCYTE CORPcall	$0	–	-100,000	-100.0%	-1.29%	–
BSX	Exit	BOSTON SCIENTIFIC CORP	$0	–	-235,000	-100.0%	-1.53%	–
ARQL	Exit	ARQULE INCcall	$0	–	-1,063,700	-100.0%	-1.78%	–
GH	Exit	GUARDANT HEALTH INCput	$0	–	-142,200	-100.0%	-1.86%	–
SYK	Exit	STRYKER CORPORATIONcall	$0	–	-60,000	-100.0%	-1.87%	–
BDX	Exit	BECTON DICKINSON & COcall	$0	–	-50,000	-100.0%	-1.91%	–
IHI	Exit	ISHARES TRput	$0	–	-100,000	-100.0%	-3.66%	–
SPY	Exit	SPDR S&P 500 ETF TRput	$0	–	-150,000	-100.0%	-6.67%	–

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR/A filed 2021-02-12

Signatures

The EDGAR filing(s) were signed by:

Alyssa Romano — Chief Compliance Officer and Chief Financial Officer

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
ICU MED INC	26	Q2 2023	4.2%
NANOSTRING TECHNOLOGIES INC	26	Q2 2023	3.3%
VIEWRAY INC	25	Q2 2023	3.2%
LIVANOVA PLC	23	Q3 2023	3.8%
ALEXION PHARMACEUTICALS INC	23	Q1 2021	4.3%
INSPIRE MED SYS INC	22	Q3 2023	3.7%
BOSTON SCIENTIFIC CORP	22	Q3 2022	4.8%
INVACARE CORP	22	Q3 2021	2.8%
ESTABLISHMENT LABS HLDGS INC	21	Q3 2023	5.0%
INTERSECT ENT INC	21	Q2 2021	2.6%

View PURA VIDA INVESTMENTS, LLC's complete holdings history.

Latest significant ownerships (13-D/G)

PURA VIDA INVESTMENTS, LLC Q3 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
Stryve Foods Holdings, LLC	April 19, 2023	1,470,649	5.6%
ICAD INC	March 15, 2023	1,277,214	5.0%
ESTABLISHMENT LABS HOLDINGS INC.	February 14, 2023	1,002,767	4.1%
Pulmonx Corp	February 14, 2023	1,216,258	3.2%
Quotient Ltd^{Sold out}	February 14, 2023	0	0.0%
Universe Pharmaceuticals INC^{Sold out}	February 14, 2023	0	0.0%
MedMen Enterprises, Inc.	April 29, 2022	139,755,072	21.4%
INVACARE CORP^{Sold out}	February 14, 2022	0	0.0%
MedAvail Holdings, Inc.	February 14, 2022	714,120	2.2%
TELA Bio, Inc.	February 14, 2022	564,120	3.9%

View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.

Latest filings

Type	Filed
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
13F-HR	2024-02-13
SC 13D/A	2023-12-29

View PURA VIDA INVESTMENTS, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

The reported total value is incorrect (585386000.0 != 585391000.0)
The reported has been restated
The reported has been amended

Export PURA VIDA INVESTMENTS, LLC's holdings